Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Mark FitzGerald

Showing results (301-310 of 325) with videos related to

Pageof 33
Sort By:
The European Respiratory Journal|July 25, 2015
A summary of the new GINA strategy: a roadmap to asthma controlHelen K Reddel, Eric D Bateman, Allan Becker, et al.
The European Respiratory Journal|November 3, 2022
Patient and physician factors associated with symptomatic undiagnosed asthma or COPDMathew Cherian, Kate M A Magner, G A Whitmore, et al.
The European Respiratory Journal|October 20, 2021
Global Initiative for Asthma Strategy 2021: executive summary and rationale for key changesHelen K Reddel, Leonard B Bacharier, Eric D Bateman, et al.
Respirology (Carlton, Vic.)|October 20, 2021
Global Initiative for Asthma Strategy 2021: Executive Summary and Rationale for Key ChangesHelen K Reddel, Leonard B Bacharier, Eric D Bateman, et al.
Archivos De Bronconeumologia|March 4, 2022
Global Initiative for Asthma Strategy 2021. Executive Summary and Rationale for Key ChangesHelen K Reddel, Leonard B Bacharier, Eric D Bateman, et al.
The Journal of Allergy and Clinical Immunology|May 18, 2016
Efficacy and safety of multiple doses of QGE031 (ligelizumab) versus omalizumab and placebo in inhibiting allergen-induced early asthmatic responsesGail M Gauvreau, Jonathan P Arm, Louis-Philippe Boulet, et al.
The New England Journal of Medicine|May 22, 2018
Dupilumab Efficacy and Safety in Moderate-to-Severe Uncontrolled AsthmaMario Castro, Jonathan Corren, Ian D Pavord, et al.
The Journal of Allergy and Clinical Immunology. in Practice|December 14, 2020
Potential Severe Asthma Hidden in UK Primary CareDermot Ryan, Heath Heatley, Liam G Heaney, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|September 10, 2020
A randomized, placebo-controlled trial evaluating effects of lebrikizumab on airway eosinophilic inflammation and remodelling in uncontrolled asthma (CLAVIER)Cary D Austin, Melissa Gonzalez Edick, Ronald E Ferrando, et al.
The Lancet. Respiratory Medicine|March 24, 2023
Use of digital measurement of medication adherence and lung function to guide the management of uncontrolled asthma (INCA Sun): a multicentre, single-blinded, randomised clinical trialElaine Mac Hale, Garrett Greene, Christopher Mulvey, et al.
Pageof 33

Showing results (301-310 of 325) with videos related to

Sort By:
Pageof 33
The European Respiratory Journal|July 25, 2015
A summary of the new GINA strategy: a roadmap to asthma controlHelen K Reddel, Eric D Bateman, Allan Becker, et al.
The European Respiratory Journal|November 3, 2022
Patient and physician factors associated with symptomatic undiagnosed asthma or COPDMathew Cherian, Kate M A Magner, G A Whitmore, et al.
The European Respiratory Journal|October 20, 2021
Global Initiative for Asthma Strategy 2021: executive summary and rationale for key changesHelen K Reddel, Leonard B Bacharier, Eric D Bateman, et al.
Respirology (Carlton, Vic.)|October 20, 2021
Global Initiative for Asthma Strategy 2021: Executive Summary and Rationale for Key ChangesHelen K Reddel, Leonard B Bacharier, Eric D Bateman, et al.
Archivos De Bronconeumologia|March 4, 2022
Global Initiative for Asthma Strategy 2021. Executive Summary and Rationale for Key ChangesHelen K Reddel, Leonard B Bacharier, Eric D Bateman, et al.
The Journal of Allergy and Clinical Immunology|May 18, 2016
Efficacy and safety of multiple doses of QGE031 (ligelizumab) versus omalizumab and placebo in inhibiting allergen-induced early asthmatic responsesGail M Gauvreau, Jonathan P Arm, Louis-Philippe Boulet, et al.
The New England Journal of Medicine|May 22, 2018
Dupilumab Efficacy and Safety in Moderate-to-Severe Uncontrolled AsthmaMario Castro, Jonathan Corren, Ian D Pavord, et al.
The Journal of Allergy and Clinical Immunology. in Practice|December 14, 2020
Potential Severe Asthma Hidden in UK Primary CareDermot Ryan, Heath Heatley, Liam G Heaney, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|September 10, 2020
A randomized, placebo-controlled trial evaluating effects of lebrikizumab on airway eosinophilic inflammation and remodelling in uncontrolled asthma (CLAVIER)Cary D Austin, Melissa Gonzalez Edick, Ronald E Ferrando, et al.
The Lancet. Respiratory Medicine|March 24, 2023
Use of digital measurement of medication adherence and lung function to guide the management of uncontrolled asthma (INCA Sun): a multicentre, single-blinded, randomised clinical trialElaine Mac Hale, Garrett Greene, Christopher Mulvey, et al.
Pageof 33